Why partner with the RBC lab for your studies?
Assays and technologies indicated in these webpages are used by the RBC lab to define pathology and is used to set biomarkers to assess the success in clinical trials. In addition to commercial instrumentation we have developed unique instruments aimed to resolve specific issues.
In most cases a shift towards normal is the goal of treatment, either by drugs or gene therapy, and monitoring these biomarkers in time by the RBC lab have contributed to the currently available treatment regimen for hemoglobinopathy patients. These assays can be performed on single samples or batched samples and will be invoiced according to the UCSF mandated pricelist. We prefer you contact us to discuss specifics of the study and samples involved to optimize results.
